WASHINGTON (Reuters) - An experimental bird flu vaccine that uses a common cold virus and bits of DNA from the H5N1 virus appears to stimulate an immune response in mice, U.S. researchers said on Thursday.
They said their experiment is a first step towards developing a next-generation bird flu vaccine that does not need to be grown for months in chicken eggs and that could protect against mutated versions of the virus.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
